Background Public health is a priority for the Chinese Government. Evidence-based decision making for health at the province level in China, which is home to a fifth of the global population, is of paramount importance. This analysis uses data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to help inform decision making and monitor progress on health at the province level.
Introduction
Over the past four decades, China has seen rapid demographic and epidemiological transitions, along with an economic boom that has already lifted millions out of poverty. Fundamental transformations in overall population health, as measured by life expectancy, child mortality, disease profile, and risk factors, have occurred and are continuing. 1 However, few studies have systema tically documented these transitions. [1] [2] [3] [4] Such information is crucial in helping population health professionals and policy makers understand the health priorities in China at the national and subnational levels.
The Healthy China 2030 plan 5, 6 is the signature national domestic population health policy and has made population health the ultimate goal of economic development and political reform. Two of the goals are to improve longevity and healthy life expectancy and to increase disease prevention. 7 Other targets include improvements in infant mortality, the environment (eg, air quality), health services and insurance (eg, chronic disease mortality), lifestyle (eg, regular exercise), and the health industry. Health equity is also a priority, 5 but health problems and access to healthcare providers and services remain heterogeneous between the provinces in mainland the National Office for Maternal and Child Health Surveillance, and the National Office for Cancer Control and Prevention, and individual researchers at academic institutions worldwide. Through such collaboration, we can bring together health infor mation from otherwise mostly siloed sources and analyse the information with the methods developed through the GBD collaboration. Here we present national and provincial results for mortality, causes of death, morbidity, and risk factors from 1990 to 2017.
Methods

Overview
We employed the suite of estimation methods for burden of disease used in GBD 2017 to assess the state of population health at the province level in China. The GBD 2017 methods have been described in full detail elsewhere. [10] [11] [12] [13] [14] [15] [16] Metrics generated in evaluating the burden of disease in China include allcause mortality; cause specific mortality and years of life lost (YLLs) for 282 causes of death; years lived with disability (YLDs) for 354 diseases and injuries and 3484 sequelae; combined health loss for 359 diseases and injuries presented as disabilityadjusted lifeyears (DALYs); and attributable deaths, YLLs, DALYs, and summary exposure values (SEVs) for 84 risk factors or clusters of risks. Metrics were also analysed in relation to the Sociodemographic Index (SDI), a composite indicator based on fertility, income per person, and years of education. Uncertainty is reported with each estimate and propagated throughout the GBD modelling process.
To ensure transparency and replicability, our study follows the Guidelines for Accurate and Transparent
Research in context
Evidence before this study A detailed analysis of 240 causes of death at the province level in China was done in the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2013. Data in China are primarily available from the Disease Surveillance Point system, the Maternal and Child Surveillance System, the Chinese Center for Disease Control and Prevention cause-of-death reporting system (reported by community health workers and hospitals at province level), cancer registries, and reports from Hong Kong and Macau. However, existing data on death, disability, and risks have not been consistently analysed over time. In this study, we apply the suite of methodologies developed for GBD 2017 to analyse systematically the burden of disease in China at the subnational level.
Added value of this study
This is the first comprehensive subnational assessment of health to include data on mortality, morbidity, combined health loss, and risks in China. Major improvements have been made to the GBD methods since the 2013 subnational analysis of population health in China. These include additional causes of death and disability, greater disaggregation of age groups, substantially expanded data sources, the development of data quality ratings, improvements to estimation models, the development of the Socio-demographic Index, consideration of summary exposure values for risk factors, and a fully updated time series of estimates, among other improvements.
Implications of all the available evidence
Subnational analysis of health patterns, including mortality, disability, and risk, provide important information for government planning at the province level. Our study identifies areas where the disease burden is being successfully reduced. It also reveals differences in health outcomes between provinces that can guide interventions, particularly in the western rural regions where health outcomes are typically poorer than in other regions. Health factors that need increased attention include high blood pressure, diet, non-communicable diseases, tobacco smoking and exposure to ambient air pollution, and chronic illnesses in the elderly. Health policies in China affect the largest population on the planet, magnifying the importance of evidence-based, data-driven decision making for health.
Health Estimates Reporting (GATHER), 17 and all data sources (except those protected by data usage agree ment), code, and results are publicly available online. A comprehensive explanation of inclusion and exclusion criteria and limitations have been previously described elsewhere.
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Geographical units and time periods
All relevant burden of disease metrics were estimated separately for the two sexes and for all age groups that are standard in GBD 2017. Our estimation processes cover the years from 1950 to 2017 for all demographic indicators, and from 1990 to 2017 for all other burden of disease metrics for mortality, morbidity, and associated risk factors. This analysis includes 34 provincelevel admin istrative units in China (Xinjiang Production and Construction Corps is excluded). These provincelevel units consist of 23 provinces, five autonomous regions, four municipalities, and two special administrative regions but are all termed provinces throughout the Article. Because of provincelevel administrative changes since 1950 (eg, the creation of Chongqing Municipality in 1997), we have used empirical data sources, including censuses and the Disease Surveillance Point system, to separate data to match the current province boundaries. Estimates are provided for the following age groups: early neonatal (0-6 days); late neonatal (7-27 days); postneonatal (28-365 days); and childhood and adult (1-4 years and all subsequent 5year age groups from 5-9 to 90-94 years, and ≥95 years). In this Article, the discussion is focused on the provincelevel burden of disease for mainland China and the two SARs
All-cause and cause-specific mortality
For allcause mortality, to ensure consistency we scaled each provincelevel estimate for the 32 provinces in mainland China to match the separately estimated all cause mortality for mainland China as a whole. Hong Kong and Macau special admin istrative regions were not included in this scaling process because the mortality and demographic data collection processes are separate from that on the mainland. Data for allcause mortality in China were derived primarily from the Disease Surveillance Point system; censuses; surveys (including the Annual Survey on Population Change and the Intercensal Survey), which provide data for children younger than 5 years, adults, and age pattern of mortality; and the Maternal and Child Health Surveillance system and OneperThousand Population Fertility Sample Survey, which provide data on children younger than 5 years. Standard GBD data processing procedures and analytical models were applied to generate allcause mortality estimates. Detailed descriptions of these methods can be found in previous GBD publications. 10, 11, 18 Causespecific mortality was estimated primarily with the GBD cause of death ensemble modelling tool, CODEm.
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Unlike allcause mortality, we estimated causespecific mortality only at the province level. Data on causes of death for the provinces were primarily derived from surveillance systems, including the Disease Surveillance Point system and the Maternal and Child Surveillance System, as well as from surveys, the China Cancer Registry, and the Chinese Center for Disease Control and Prevention causeofdeath reporting system. The causeofdeath data in the Disease Surveillance Point system are a rich source for understanding mortality levels and trends in China from the early 1990s onwards. Since 1978, this national system has included 605 surveillance points with 323·8 million population covered.
Since the SARS epidemic in 2003, China has been establishing a national electronic causeofdeath reporting system. Over the past 15 years, and especially since 2008, coverage and completeness of recording have increased substantially. In 2016, the system covered more than 80% of the deaths nationally. Given the heterogeneous nature of the epidemiological profiles across provinces and between urban and rural regions, and the fact that completeness of reported deaths in and out of hospital differ, we stratified the 2852 counties in China by urban and rural status, as defined in the 2010 census in China (appendix). We then reweighted reported inhospital and outofhospital deaths in counties without Disease Surveillance Points by using the fractions of deaths reported by the system in provinces with urban or rural status. Provincelevel causespecific mortality was generated from these estimates by combining stratum level mortality weighted by the size, age, and sex of the population in each stratum per year. Causes of death for Hong Kong and Macau were based on medical certification data reported to WHO. All causeofdeath data for China were mapped from the codes in the International Classification of Diseases ninth or tenth edition to the GBD cause hierarchy. To ensure consistency across estimates, causespecific mortality estimates were scaled to match allcause mortality estimates with the GBD CoDCorrect process.
Fertility and population
To ensure that estimates of key demographic indicators, such as population and fertility, were internally consistent with estimates of burden of disease, we estimated these factors at the national and subnational levels. Agespecific fertility rates for women aged 10-54 years in 5year age groups were estimated from 1950 to 2017 by methods detailed by Murray and colleagues. 12 Input data on agespecific fertility were extracted from censuses, annual surveys on population change, and surveys on fertility, including the Oneper Thousand Population Fertility Sample Survey. To ensure internal consistency, we scaled estimates of agespecific fertility rates across the 32 mainland provinces to estimated agespecific fertility rates for the mainland as one unit. 12 This method uses the esti mates of agespecific vital rates on mortality and fertility to ensure maximum internal consistency.
Morbidity and disability-adjusted life-years
Prevalence and incidence of nonfatal outcomes were primarily estimated with the Bayesian metaregression method DisModMR 2.1. 13 Briefly, this metaanalysis tool uses a compartmental model structure with a series of differential equations that synthesise sparse and hetero geneous epidemiological data.
14 Data on nonfatal outcomes were derived primarily from published studies, national surveys, cancer registries, the Chinese Center for Disease Control and Prevention causeofdeath reporting system, and hospital inpatient data. DALYs represent a combined measure of health loss from fatal and nonfatal outcomes. They were estimated as the sum of YLLs and YLDs.
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Risk factors
Exposures, attributable mortality, and attributable DALYs were estimated for 84 risk factors categorised as be havioural, environmental and occupational, or metabolic. Briefly, data on relative risks and exposures were derived from over 46 000 empirical data points primarily extracted from randomised controlled trials and cohort and pooled cohort studies. Statistical models were used to pool empirical data and adjust for biases while accounting for effects of relevant covariates. With the counterfactual scenario of theoretical minimum risk exposure level, we estimated attributable burden based on the estimated exposure per risk. Finally, we computed a summary exposure value (SEV) for each risk included in our analysis, by province over time. Each SEV ranges from 0 to 100% and indicates what percentage of the population is exposed to the maximum possible level of a specific risk. 
Socio-demographic Index
The SDI is a combined measure of the rescaled total fertility rates among women younger than 25 years, years of educational attainment in the population older than 15 years, and lagdistributed income per person. 12 Each factor is scaled from 0 to 1, and the geometric mean of the three values produces a final index score of 0-1. The national SDI for China in 2017 was 0·71 and at the province level was 0·47-0·86. 12 To generate expected values based on the SDI, we used Gaussian regression to estimate the relationship between SDI and health metrics for each age, sex, year, and province. We then compared observed values with ex pected values.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of
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YLDs per 100 000 population (95% UI) Percentage change (95% UI) figure 1 . For 18 causes, the number of DALYs increased from 1990 to 2017. Stroke and ischaemic heart disease were the leading causes of allage DALYs in 2017, replacing lower respiratory infections and neonatal disorders in 1990. The absolute numbers and rates per 100 000 population for allage DALYs increased sub stantially for stroke and ischaemic heart disease between 1990 and 2017 (DALY counts increased by 46·8%, 95% UI 38·1-53·9 and 125·3%, 109·4-138·5, respectively), but agestandardised stroke decreased by 33·1% (29·8-37·4) during this period. High systolic blood pressure accounted for 2·54 million deaths (95% UI 2·26 million-2·82 million) in 2017, with 95·7% of these deaths (95·6-96·4) being due to cardio vascular diseases. The agestandardised DALYs per figure 2 . High systolic blood pressure, smoking, diet high in sodium, and particulate matter pollution were the top four risk factors for both number of deaths and percentage of DALYs in 2017. High systolic blood pressure accounted for 2·54 million (95% UI 2·26 million to 2·82 million) deaths in 2017, of which 95·7% (95·6-96·4) were due to cardiovascular diseases. Alcohol use was the tenth leading contributor to the number of deaths. Each of the eight following risks accounted for more than 5% of DALYs in 2017: smoking, high systolic blood pressure, diet high in sodium, particulate matter pollution, high bodymass index, high fasting plasma glucose, alcohol use, and diet low in whole grains.
When provincelevel agestandardised YLLs were compared with the national average for the top 20 causes, Beijing and Macau were the only two provinces with significantly lower values for all top 20 causes ( figure 3 ). In Shanghai, agestandardised YLLs were significantly lower than the national mean for all top 20 causes except for colon and rectum cancer and congenital birth defects, which were significantly higher. In Hong Kong, all were significantly lower except colon and rectum cancer, which was significantly higher, and selfharm, which did not differ significantly from the national average.
In all provinces, the ratio of observed to expected agestandardised allcause DALYs per 100 000 population was lower than expected based on the SDI (figure 4). 12 provinces had an observed agestandardised allcause DALYs per 100 000 population at least 30% lower than expected. These provinces have widely varying levels of social and economic development (appendix). Thus, although lowerthanexpected values are unsurprising for the 16 provinces with high and highmiddle SDI values and good public health intervention programmes, such as Zhejiang, it is noteworthy that the remaining 18 provinces with lower levels of economic development, such as Ningxia, also achieved these results. Agestandardised DALYs for ischaemic heart disease, Alzheimer's disease, headache disorder, and low back pain were lower than expected in all provinces in 2017 (figure 4). All provinces had higher than expected agestandardised DALYs for liver cancer, with the observedtoexpected ratio ranging from 2·04 to 6·88. For lower respiratory infections, congenital birth defects, diabetes mellitus, and neonatal disorders, nearly all provinces had agestandardised DALYs lower than expected.
The percentage changes in agestandardised SEVs for the top ten risk factors from 1990 to 2017 in China were greatest for high bodymass index and ambient particulate matter pollution (appendix). Agestandardised SEVs for high bodymass index, ambient particulate matter pollution, alcohol use, high blood pressure, and high LDL cholesterol increased for all mainland provinces, with high bodymass index increasing the most by 185% (95% UI 113·1-247·7), followed by ambi ent particulate matter pollution (88·5%, 66·4-116·4). Conversely, agestandardised SEVs for low fruit con sumption decreased in all 34 provinces during the time period. High fasting plasma glucose increased in all provinces except Hainan. We found substantial hetero geneity between provinces in the change of SEVs by risk. 
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The agestandardised SEV for high sodium consumption increased in 16 of 34 provinces. In 2017, smoking was the leading risk factor for DALYs in China overall and in 21 provinces, and was second or third in all remaining provinces (appendix). High systolic blood pressure and diet high in sodium were the second and third leading risks for DALYs at the national level. Smoking, high blood pressure, and diet high in sodium were the top three risk factors for DALYs in all provinces in mainland China except seven, where diet high in sodium ranked between fourth and sixth. Notably, high systolic blood pressure or smoking was the first or second leading risk factor for DALYs in all provinces except Xinjiang. Diet low in vegetables was ranked much lower in Beijing, Shanghai, Guangdong, Jiangsu, Zhejiang, and Fujian than in the other provinces.
Discussion
Over the period 1990 to 2017, health outcomes underwent dramatic changes across the provinces of China. The rates of YLLs, YLDs, and DALYs due to communicable, maternal, neonatal, and nutritional conditions largely decreased during the study period, while those caused by non communicable diseases generally increased. The national burden of disease has, therefore, shifted consid erably, with communicable, maternal, neonatal, and nutritional conditions accounting for a much smaller proportion of DALYs in 2017 than in 1990. Exposure to some risk factors is rising, particularly high fasting plasma glucose, high systolic blood pressure, high bodymass index, and, in many provinces, ambient particulate matter pollution. Compared with other locations at a similar level of development as measured by SDI, China has unusually high levels of stroke, chronic obstructive pulmonary disease, lung cancer, liver cancer, neck pain, and stomach cancer. The top two leading causes of disease burden by allage DALYs are stroke and ischaemic heart disease, which have seen significant increases in numbers and crude rates of allage DALYs between 1990 and 2017, even though agestandardised DALYs for stroke have significantly decreased during the same time period. At the province level the disease burden from these two disorders shows substantial hetero geneity. The provinces with higher YLL rates due to stroke and ischaemic heart disease are those with poorer economic performance, except Shandong. Further investigation 0·65  0·70  0·63  0·67  0·72  0·75  0·79  0·68  0·70  0·89  0·82  0·76   0·77  0·80  0·82  0·70  0·71  0·74  0·79   0·69  0·82  0·73  0·76  0·68  0·72  0·75   0·82  0·75  0·94  0·80 0·95  0·98  1·67  0·98  1·72   1·32  0·94  1·09  1·80  1·18  0·85  1·18   1·81  2·49  1·23  1·73  1·00  1·75  1·30   0·84  1·56  1·46  0·78  1·18   3·77   5·58   2·92   3·49   3·45  2·11  3·48  4·65  2·14  4·64  6·88  2·23  4·54  2·79  5·17  3·81   4·37  4·04  3·15  3·91  3·66  3·43  3·83   2·79  3·26  2·22  3·96  2·04  2·33  4·42   2·89  2·45  2·47  2·34  3·81   1·23   0·70   0·91   0·61   1·40  0·69  1·56  1·20  0·83  1·02  1·14  1·29  0·88  1·15  1·93  1·23   1·41  1·50  1·08  1·16  1·33  1·19  1·53   0·95  0·88  0·86  1·44  0·66  1·02 0·90   0·92   0·91   0·73   0·87  0·73  0·68  0·96  0·89  0·95  0·95  0·74  0·82  0·96  0·88  0·91   0·93  0·99  0·99  0·99  0·78  0·79  0·98   0·73  0·81  0·79  0·94  0·69  0·84  0·79   0·97  0·88  0·91  0·98  0·91   1·31   0·95   1·08   1·21   1·23  1·06  1·24  1·20  1·39  1·18  1·48  2·28  1·34  1·51  1·18  1·21   1·23  1·47  1·22  1·17  1·32  1·23  1·25   1·32  1·31  1·30  1·16  1·09  1·22  1·36   1·16  1·51  1·95  1·80  1·17   0·87   0·76   1·09   0·88   0·91  0·72  0·85  0·87  1·00  0·88  0·84  0·89  0·87  0·89  0·82  0·92   0·99  0·86  0·84  0·81  0·86  0·82  0·75   0·84  1·05  0·86  1·03  0·70  0·80  0·84   0·77  0·78  0·82 0·42  0·43  0·43  0·45   0·35  0·44  0·42  0·41  0·46  0·34  0·41   0·47  0·47  0·34  0·30  0·21  0·43  0·46   0·37  0·51  0·44  0·32  0·18   1·32   0·74   1·03   1·23   1·40  1·22  1·37  1·32  1·42  1·26  1·35  1·44  1·34  1·32  1·32  1·36   1·34  1·34  1·30  1·29  1·39  1·31  1·29   1·39  1·40  1·34  1·29  1·52  1·33  1·37   1·22  1·46  1·34  1·41  1·28   1·19   1·71   1·13   1·20   1·26  1·06  1·24  1·11  1·30  1·18  1·40  1·16  1·18  1·20  1·32  1·29   1·26  1·29  1·26  1·04  1·15  1·29  1·25   1·30  1·31  1·21  1·24  0·84  1·12  1·09   1·31  1·38  1·29 1·13   1·37   1·24   1·21   1·07  1·31  1·09  1·13  1·06  1·19  1·11  1·04  1·12  1·13  1·14  1·11   1·23  1·12  1·15  1·16  1·08  1·15  1·17   1·08  1·07  1·08  1·09  1·27  1·13  1·09   1·24  0·99  1·12  1·07  1·16   0·84   0·94   0·36   0·43   0·78  0·49  0·59  0·67  1·00  0·63  0·85  0·74  0·59  1·17  0·65  0·87   0·82  0·87  0·98  0·81  0·91  0·63  0·68   1·10  1·16  0·90  0·90  0·76  0·91  0·76   0·81  0·56  1·08  0·95 using the associated risk factors analysed in our study for these two diseases will be necessary for policy makers at the national and provincial levels to develop targeted intervention programmes to ease the associated burden. The decreasing burden of communicable, maternal, neonatal, and nutritional conditions has occurred alongside rapid declines in maternal mortality and mortality among children younger than 5 years. 23, 24 Rapid and sustained economic growth and increasing levels of educational attainment are likely to have con tributed to these changes. 25, 26 The observed burden indicates that China has been more successful than expected based on the SDI in lessening these health burdens. China has used a range of national programmes to target interventions for communicable, maternal, neonatal, and nutritional conditions, 4, 27 particularly in women and children. One of the most ambitious among such programmes is the Reducing Maternal Mortality and Eliminating Neonatal Tetanus Program, which aims to improve obstetric care quality systematically in every county of China. Maternal mortality has declined in 98·6% of all counties in China since the launch of this programme in 2000. 28 These factors constitute credible explanations for the greaterthanexpected progress.
Agestandardised DALYs per 100 000 population have also reduced rapidly in many provinces for several non communicable diseases and injuries, most notably self harm, stomach cancer, oesophageal cancer, and chronic obstructive pulmonary disease. Suicide rates have consistently declined since 1990, particularly among young women. This trend is partly explained by urbani sation and development accompanied by improved opportunities for women and young people. 29, 30 Declines in some cancers alongside increases in others reinforces the heterogeneous burden of cancers and the need for specific, targeted approaches for cancer prevention and control according to province and cancer type. For instance, DALYs for liver cancer were higher than expected in all provinces, whereas the greatest relative difference in the observed to expected ratio across provinces was for lung cancer. Reduced disease burden from chronic obstructive pulmonary disease is consistent with previous findings from the region, which attributed declines primarily to improvements in access to health care, diagnosis, and treatment. 3 Declines in mortality varied across provinces, highlighting remaining health disparities and the need to continue to imple ment interventions to improve care and reduce related exposures, such as to tobacco and pollution.
An important aspect of the transition underway in China is the rising mean age of the population, which has been driven by a rapid decline in fertility rate from the 1970s and declining agespecific mortality rates. 12 With the mean population age rising, agerelated conditions, such as musculoskeletal disorders, have increasing importance for the health system. Musculo skeletal disorders can cause important limitations to general activity and work and introduce considerable economic and medical burdens to individuals, families, and governments. However, these disorders receive little attention from public health policy makers. In addition, a growing portion of the workingage population spends most of its time in office environments, leading to increased prevalence of low back and neck pain, which suggests the need for relevant policies to prevent this occupational hazard. 31 High systolic blood pressure and smoking are the leading risk factors. Government policies, such as Healthy China 2020 and 2030, have been put in place partly to promote risk reduction and encourage healthier lifestyles. 5 Healthy China 2030 is a national health policy issued by the central Government of China that aims to adopt the most pertinent health policies or strategies for improving the overall health of the Chinese population between 2016 and 2030. 5 We have found some slow progress in reducing tobacco consumption, but, surprisingly, no progress in lowering systolic blood pressure, which has increased since 1990 despite reductions in dietary sodium in 16 provinces. Given the huge burden of elevated systolic blood pressure and tobacco consumption, policies to address these two risk factors need to be intensified.
Many dietrelated risks increased from 1990 to 2017, particularly high bodymass index. Changing lifestyles, including increased consumption of red meat and decreasing levels of physical activity, have probably driven the rapidly rising rates of diabetes in China. 32, 33 The Chinese government has started to deal with the chal lenges posed by noncommunicable diseases, many of which result from dietary risks. A wide range of control and prevention strategies, policies, regulations, and plans have been put in place to address the rising incidence of these disorders, including the national MediumtoLong Term Plan for the Prevention and Treatment of Chronic Diseases (2017-2025); 34 the Development of National Demonstration Areas for Comprehensive Prevention and Control of Noncommunicable Diseases; 35 the Healthy Life Style for All 2017-2025 Action Protocol; 36 the Air Pollution Prevention and Control Action Plan; 37 and salt reduction programmes. 38 The government has also included hypertension and diabetes management in the National Basic Public Health Service Project since 2009. 39 These national polices provide guidance on how to involve multiple departments and motivate societies to participate and work together against noncommunicable diseases.
Environmental overhauls and the national transition to a greener economy might eventually reduce pollution related cancers and chronic obstructive pulmonary disease. [40] [41] [42] Particulate matter pollution is the fourth leading risk factor at the national level for deaths and DALYs. Tackling air pollution has become a priority for the Chinese government. The State Counsel issued a National Air Pollution Prevention and Control Action Plan in 2013, in which they identified ten detailed strategies and measures for implementation, including all related government agencies. 43 Pollution control targets have been set for heavily polluted areas, such as the Beijing, Tianjin, and Hebei region, the Yangtze River Delta, and the Pearl River Delta to reduce concentrations of particular matter smaller than 2·5 µm in diameter by 25%, 20%, and 15%, respectively, over 5 years. Beijing in particular needs to reduce concentration to 60 µg/m³ per year. Although evaluation of the action plan is needed, our findings suggest that more stringent regu lations should be put in place to reduce the burden caused by ambient air pollution.
Mortality rates from liver cancer was much higher than expected across provinces, but is declining. 44 Increased coverage of hepatitis B vaccination could contribute to further declines in liver cancer. 45 Compared with the 1992 prerecombinant vaccine survey in China, 46 hepatitis B prevalence had declined by 46% in 2006 and by 52% in 2014. Among children younger than 5 years, the decline was 97% over this time period. 47 China's hepatitis B prevention programme, which was targeted toward interrupting perinatal transmission, has been highly successful and is increasingly effective. 47 Vaccination against hepatitis B virus has been included in all childhood vaccinations since 1992, but has only been provided free of charge since 2005. 48 The urban, coastal, and wealthier provinces and cities in eastern China generally had better health outcomes than those in the west, although health burden by cause varied substantially between provinces. Although various risks are often intensified in urban areas, such as pollution, rapid disease spread, and sedentary lifestyle behaviours, 49 these factors seem to be offset at least partly by better access to health care and greater wealth than in rural areas. In addition, cities attract younger, workingage populations-both permanent and migrant-and past national health policies tended to focus on densely populated urban areas. The western region of China is more ethnically diverse and dispersed than the east, which increases the difficulty of providing access to care. 50, 51 Of note, risks related to poor diet and sedentary lifestyles are not confined to urban areas. Providing prevention and care for rural, elderly, and migrant populations will be a major challenge as China moves toward universal health coverage.
Overall, China and its provinces have outperformed expected improvements based on SDI. Using SDI in our analysis has helped to identify areas where potential health policies and intervention programmes at the national and province levels have helped improve the population health in China. However, the marked diversity in health outcomes between provinces indicates that health equity remains a challenge. Differences between provinces remain large compared with those in some other nations. Improving health equity has long been a government priority, and Healthy China 2030 includes justice and equity as one of four core principles. 5, 52 Equity at the subnational level can only be achieved if health patterns and trends can be monitored and analysed at that or even more granular levels. China's vast and growing economy puts it in the unique position to prevent and treat the disease burden if equipped with sufficient data to guide investments. Reducing inequalities will require targeted strategies to lessen major risk factors and diseases in each province and needs further and much more detailed analysis.
Our results provide important evidence for tailored, provincespecific policy development and interventions. These findings can be used by governments at the subnational level to identify major health problems and facilitate priority setting. Although it was not the objective of this study to investigate the drivers behind the heterogeneity in disease burden and its trends at the provincead level in China in the past three decades, our findings help to evaluate the effectiveness of various national and provincial public health policies and intervention programmes in the same period.
This study is subject to all the limitations of the GBD studies. [10] [11] [12] [13] [14] [15] [16] First, for the estimation of allcause mortality in China, we used death distribution methods to evaluate the completeness of the Disease Surveillance Point system, but these methods have wide uncertainty. Second, although uncertainty was propagated in each step of our analytical process, some uncertainties might have not been fully captured in our study. Third, although we have strong evidence on fatal outcomes, we have less information on nonfatal outcomes. Fourth, comorbidity adjustment in our study assumes independent distri butions of comorbid conditions, but they vary by cause, age, sex, and location. 13 Fifth, the current DisModMR 2.1 tool does not capture the cohort nature of some diseases, including lung cancer. Sixth, the uncertainty of DALYs might be underestimated because we assume inde pendence of YLLs from YLDs. Seventh, the time trends of certain diseases might be affected by changes in diagnostic technology over time. Eighth, for allcause mortality, the censuses provide adequate data on mortality, fertility, and population for each province, but the Disease Surveillance Point system covers fewer counties and districts in remote and poorer provinces. Lack of more robust causespecific mortality data from these provinces affects the precision of our estimates. Ninth, at the province level, we assume that inhospital and outofhospital data in the Disease Surveillance Point System are representative. The accuracy of our estimates is determined by data availability, and although overall completeness of death registration and the percentage of causeofdeath data that were well certified were both over 60% in China in 2016, data sparsity in some regions remains an issue.. Tenth, we used alcohol product sales data to produce estimates of alcohol use. As alcohol consumption among Chinese residents in 1990 was mainly of homemade products, the estimated change in alcohol use between 1990 and 2017 might not be accurate.
China has been successful in improving the health of its more than 1 billion citizens, but health outcomes continue to depend on geography. Health is better over all in more industrialised, wealthier eastern provinces than in more rural, poorer western provinces. Improvements in the disease burden, particularly of communicable, maternal, neonatal, and nutritional conditions and some noncom municable diseases, are very encouraging. Nevertheless, the burden of ischaemic heart disease and other chronic diseases continues to grow and needs increased public health attention and investment. The potential effect of major environmental policy changes remains to be seen, but similar overhauls of diet and lifestyle behaviours will probably be needed to reduce leading risks for noncommunicable diseases in China. The levels and trends in burden of disease differ significantly at the province level. Continued monitoring and analysis of health trends could maximise the effectiveness of investments in health and have the potential to guide other countries in the region and the world in successful approaches to evidencebased health policies. In addition, future research needs to investi gate the drivers of the observed heterogeneity in the epidemiological and demographic transitions in China. Rigorous evaluations of the various public health programmes and interventions can also help guide appropriate policies in China and other developing countries.
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